'Constantly Being Chased': Cutting-Edge Gene Therapy Developers Moving Fast In China
Half US Price Still Too Costly?
Executive Summary
Plagued by a scandal which gained global attention a few years go, the gene therapy sector has recovered and is now thriving in China. But a drive for innovation, combined with ready cash for aspiring start-ups, may not translate into leaps and bounds in the field due to challenges unique to these latest treatments, including manufacturing, durability and coverage.